Canaccord Genuity Downgrades Perrigo Co. (PRGO) to Hold; Limited Upside; Prefers Watson (WPI)

July 12, 2012 7:03 AM EDT Send to a Friend
Get Alerts PRGO Hot Sheet
Price: $118.92 +0.90%

Rating Summary:
    11 Buy, 4 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 18 | New: 13
Trade PRGO Now!
Canaccord Genuity downgraded Perrigo Co. (NASDAQ: PRGO) from Buy to Hold with a price target of $125.00.

Analyst, Randall Stanicky, said, "We still see PRGO as one of the highest quality names in healthcare, though we see near-term upside hurdles linked to (1) heavy “safety” trade present in the stock, (2) less attractive set-up into August guidance and (3) valuation we think is full, leaving upside linked to EPS. We leave our $125 target and EPS estimates unchanged and continue to like PRGO on pull-backs."

Stanicky prefers mid-cap pharma stock Watson Pharmaceuticals (NYSE: WPI), which trades at ~ 50% p/f discount to PRGO.

For an analyst ratings summary and ratings history on Perrigo Co. click here. For more ratings news on Perrigo Co. click here.

Shares of Perrigo Co. closed at $114.69 yesterday, with a 52 week range of $75.89-$119.29.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Canaccord Genuity

Add Your Comment